-
Clinical Presentation and Outcomes of Diabetic Ketoacidosis in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-17 Jennifer L Grasch, Sydney Lammers, Florencia Scaglia Drusini, Selina S Vickery, Kartik K Venkatesh, Stephen Thung, Monique E McKiever, Mark B Landon, Steven Gabbe
To examine the presentation, management, and outcomes of pregnancies complicated by diabetic ketoacidosis (DKA) in a contemporary obstetric population.
-
Continuous Glucose Monitoring for Diabetes Management During Pregnancy: Evidence, Practical Tips, and Common Pitfalls. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-17 Ashley N Battarbee, Celeste Durnwald, Lynn M Yee, Amy M Valent
Continuous glucose monitoring (CGM) has the potential to revolutionize diabetes management during pregnancy by providing detailed and real-time data to patients and clinicians, overcoming many of the limitations of self-monitoring of blood glucose. Although there are limited data on the role of CGM to improve pregnancy outcomes in patients with type 2 diabetes or gestational diabetes, CGM has been
-
Optimal Timing of Delivery for Pregnant Individuals With Mild Chronic Hypertension. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-17 Torri D Metz, Hui-Chien Kuo, Lorie Harper, Baha Sibai, Sherri Longo, George R Saade, Lorraine Dugoff, Kjersti Aagaard, Kim Boggess, Kirsten Lawrence, Brenna L Hughes, Joseph Bell, Rodney K Edwards, Kelly S Gibson, David M Haas, Lauren Plante, Brian Casey, Sean Esplin, Matthew K Hoffman, Kara K Hoppe, Janelle Foroutan, Methodius Tuuli, Michelle Y Owens, Hyagriv N Simhan, Heather Frey, Todd Rosen, Anna
To investigate the optimal gestational age to deliver pregnant people with chronic hypertension to improve perinatal outcomes.
-
Elevated Blood Pressure in Pregnancy and Long-Term Cardiometabolic Health Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-16 Christine Field, William A Grobman, Jiqiang Wu, Alan Kuang, Denise M Scholtens, William L Lowe, Nilay S Shah, Sadiya S Khan, Kartik K Venkatesh
To examine the association between elevated blood pressure (BP) in the early third trimester and cardiometabolic health 10-14 years after delivery.
-
Continuous Glucose Monitoring-Derived Differences in Pregnancies With and Without Adverse Perinatal Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-11 Celeste Durnwald, Roy W Beck, Zoey Li, Elizabeth Norton, Richard Bergenstal, Mary Johnson, Sean Dunnigan, Matthew Banfield, Katie Krumwiede, Judy Sibayan, Peter Calhoun, Anders L Carlson
To evaluate whether continuous glucose monitoring (CGM)-derived glycemic patterns observed throughout pregnancy were associated with adverse perinatal outcomes, specifically fetal growth disorders and hypertensive disorders of pregnancy (HDP).
-
Duration of Induction of Labor for Second-Trimester Medication Abortion and Adverse Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-11 Ashish Premkumar, Vanya Manthena, Jocelyn Wascher, Eryn K Wanyonyi, Camille Johnson, Lahari Vuppaladhadiam, Julie Chor, Beth A Plunkett, Isa Ryan, Olivert Mbah, Jungeun Lee, Emily Barker, Laura Laursen, Leanne R McCloskey, Sloane L York
To evaluate the relationship between duration of labor during second-trimester medication abortion and adverse outcomes.
-
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Infection During Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-11 Torri D Metz, Harrison T Reeder, Rebecca G Clifton, Valerie Flaherman, Leyna V Aragon, Leah Castro Baucom, Carmen J Beamon, Alexis Braverman, Jeanette Brown, Tingyi Cao, Ann Chang, Maged M Costantine, Jodie A Dionne, Kelly S Gibson, Rachel S Gross, Estefania Guerreros, Mounira Habli, Jennifer Hadlock, Jenny Han, Rachel Hess, Leah Hillier, M Camille Hoffman, Matthew K Hoffman, Brenna L Hughes, Xiaolin
To estimate the prevalence of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) after infection with SARS-CoV-2 during pregnancy and to characterize associated risk factors.
-
Diabetic Ketoacidosis and Adverse Outcomes Among Pregnant Individuals With Pregestational Diabetes in the United States, 2010-2020. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-11 Timothy Wen, Alexander M Friedman, Cynthia Gyamfi-Bannerman, Camille E Powe, Nasim C Sobhani, Gladys A Ramos, Steven Gabbe, Mark B Landon, William A Grobman, Kartik K Venkatesh
To assess the frequency of, risk factors for, and adverse outcomes associated with diabetic ketoacidosis (DKA) at delivery hospitalization among individuals with pregestational diabetes (type 1 and 2 diabetes mellitus) and secondarily to evaluate the frequency of and risk factors for antepartum and postpartum hospitalizations for DKA.
-
Assessment and Treatment of Vaginitis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-11 Caroline M Mitchell
Vaginitis is the presenting symptom at millions of office visits each year in the United States. Although treatment of sporadic cases is often straightforward, recurrent cases present both diagnostic and treatment challenges. Molecular diagnostic tests are likely superior to in-office microscopy for most clinicians and most cases. In both recurrent bacterial vaginosis and recurrent vulvovaginal candidiasis
-
Clinical Outcomes Associated with a Remote Postpartum Hypertension Monitoring Program. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-02 Lara S Lemon, Beth Quinn, Anna Binstock, Jacob C Larkin, Hyagriv N Simhan, Alisse Hauspurg
To evaluate differences in health care utilization and guideline adherence for postpartum individuals with hypertensive disorders of pregnancy (HDP) who are engaged in a remote monitoring program, compared with usual care.
-
Prophylactic Radiologic Interventions for Postpartum Hemorrhage Control in Women With Placenta Accreta Spectrum Disorder: A Systematic Review and Meta-analysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-07-02 Lisanne R Bonsen, Kosma Sleijpen, Joris Hendriks, Thijs A J Urlings, Olaf M Dekkers, Saskia le Cessie, Marc van de Velde, Pema Gurung, Thomas van den Akker, Johanna G van der Bom, Dacia D C A Henriquez
To quantify the association between prophylactic radiologic interventions and perioperative blood loss during cesarean delivery in women with placenta accreta spectrum disorder through a systematic review and network meta-analysis.
-
Special Supplemental Nutrition Program for Women, Infants, and Children Enrollment and Adverse Pregnancy Outcomes Among Nulliparous Individuals. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-27 Kartik K Venkatesh, Xiaoning Huang, Natalie A Cameron, Lucia C Petito, Jennifer Garner, Amy Headings, Andrew S Hanks, William A Grobman, Sadiya S Khan
To evaluate the relationship between changes in Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) enrollment during pregnancy from 2016 to 2019 and rates of adverse pregnancy outcomes in U.S. counties in 2019.
-
Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-27 Taïna Laurore Pritts, Meghan Ogden, William Parker, Jennifer Ratcliffe, Elizabeth A Pritts
To evaluate fertility outcomes based on size and number of intramural leiomyomas and outcomes after removal.
-
Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-18 Isabella Johnson, Andrea Ries Thurman, Katherine A Cornell, Jessica Hatheway, Clint Dart, C Paige Brainard, David R Friend, Andrew Goldstein
To assess the efficacy of topical sildenafil cream, 3.6% among healthy premenopausal women with female sexual arousal disorder.
-
Patient Preferences for Immediate Compared With Delayed Postpartum Intrauterine Device Placement. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-18 Theresa Christensen, Susanna Ostrowski, Arden McAllister, Blythe Bynum, Marilyn M Schapira, Sarita Sonalkar
To use choice-based conjoint survey methodology to evaluate patient values and decision making regarding immediate compared with delayed placement of postpartum intrauterine devices (IUDs).
-
Inpatient Hospital Costs and Route of Hysterectomy for Management of Benign Uterine Disease in the 90-Day Global Billing Period. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-13 Hope H Bauer, Amine Sahmoud, Stephen P Rhodes, David Sheyn
To compare inpatient hospital costs and complication rates within the 90-day global billing period among routes of hysterectomy.
-
Insulin Management for Gestational and Type 2 Diabetes in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-13 Amy M Valent, Linda A Barbour
Insulin is preferred as the first-line agent for glucose management of gestational diabetes mellitus and type 2 diabetes in pregnancy when nutritional and lifestyle modifications are unable to achieve pregnancy-specific glucose targets. Individual heterogeneity in defects of insulin secretion or sensitivity in liver and muscle, unique genetic influences on pregnancy glycemic regulation, and variable
-
Predicting Endometrial Hyperplasia and Endometrial Cancer on Recurrent Abnormal Uterine Bleeding. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-13 Unyamanee Veeranaraphanit, Nungrutai Saeaib, Wisarut Srisintorn
To develop predictive models for endometrial hyperplasia and endometrial cancer in patients with recurrent abnormal uterine bleeding (AUB).
-
Congenital Syphilis in Live Births: Adverse Outcomes, Hospital Length of Stay, and Costs. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-13 Han-Yang Chen, Jeffrey D Klausner, Irene A Stafford
To examine temporal trends and risk factors for congenital syphilis in newborn hospitalizations and to evaluate the association between adverse outcomes and congenital syphilis and health care utilization for newborn hospitalizations complicated by congenital syphilis.
-
Optimizing Opioid Prescription Quantity After Cesarean Delivery: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-10 Marcela C Smid, Rebecca G Clifton, Kara Rood, Sindhu Srinivas, Hyagriv N Simhan, Brian M Casey, Monica Longo, Ruth Landau, Cora MacPherson, Anna Bartholomew, Amber Sowles, Uma M Reddy, Dwight J Rouse, Jennifer L Bailit, John M Thorp, Suneet P Chauhan, George R Saade, William A Grobman, George A Macones
To test whether an individualized opioid-prescription protocol (IOPP) with a shared decision-making component can be used without compromising postcesarean pain management.
-
Individual-Level and Community-Level Predictors of Healthy Pregnancy Outcomes in Multigravid Black Women. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Valene Garr Barry, Samantha L Martin, Camille Schneider-Worthington, Peinan Zhao, Candice L Woolfolk, Randi Foraker, Kia L Davis, Jeannie C Kelly, Nandini Raghuraman, Sarah K England, Ebony B Carter
To identify individual- and community-level factors that predict the odds of multigravid Black women having consecutive pregnancies without adverse pregnancy outcomes.
-
Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Gabriel Levin, Jason D Wright, Yechiel Z Burke, Kacey M Hamilton, Raanan Meyer
To describe the rate and surgical outcomes of sentinel lymph node (SLN) biopsy in patients with endometrial intraepithelial neoplasia (EIN).
-
Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Anna E Denoble, Gabriela Vazquez-Benitez, Sangini S Sheth, Christina M Ackerman-Banks, Malini B DeSilva, Jingyi Zhu, Matthew F Daley, Darios Getahun, Nicola P Klein, Kimberly K Vesco, Stephanie A Irving, Jennifer Nelson, Joshua T B Williams, Simon J Hambidge, James G Donahue, Eric S Weintraub, Elyse O Kharbanda, Heather S Lipkind
Coronavirus disease 2019 (COVID-19) vaccination is recommended in pregnancy to reduce the risk of severe morbidity from COVID-19. However, vaccine hesitancy persists among pregnant people, with risk of stillbirth being a primary concern. Our objective was to examine the association between COVID-19 vaccination and stillbirth.
-
Ectopic Prostatic Tissue in Female Urethral Diverticulum. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Annika Sinha, Sarah Cantrell, Diana M Kozman, J Eric Jelovsek
Ectopic prostatic tissue in female patients is rare. It is theorized that the presence of prostatic tissue in female patients is likely a Wolffian remnant or transformation of hormonally mediated tissue of the uterus, cervix, Skene's gland, and, rarely, periurethral tissue. Due to the increase in the use of testosterone and gender-affirming therapies, it is important to understand the role of testosterone
-
Validation of a Vaginal Birth After Cesarean Delivery Prediction Model Without Race and Ethnicity in Individuals With Two Prior Cesarean Deliveries. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Lillian H Goodman, Amanda A Allshouse, Ann M Bruno, Torri D Metz
Previous models for prediction of vaginal birth after cesarean (VBAC) relied on race and ethnicity, raising concern for bias. In response, the Maternal-Fetal Medicine Units Network (MFMU) created a new prediction model without race and ethnicity for individuals with one prior cesarean delivery. We performed a secondary analysis of the MFMU Cesarean Registry database to evaluate whether the MFMU VBAC
-
Lasers in Gynecology. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Cheryl B Iglesia, Jennie Eunsook Choi, Yona Tadir
The first published reports on the use of laser for cervical pathology date back to 1973. Technical advancements in flexible and rigid laser fibers revolutionized video laser laparoscopy in the 1990s. Fractionated lasers have been used to treat vulvovaginal symptoms associated with genitourinary syndrome of menopause, lichen sclerosus, and urinary incontinence. Review of available data suggests that
-
Racial Disparities in Newborn Drug Testing After Implementation of Question-Based Screening for Prenatal Substance Use. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-06 Alexandra Soos, Melissa Plegue, Adam Darwiche, Lauren Oshman, Christopher J Frank
To examine the association of universal question-based screening for prenatal substance use on racial inequities in prenatal and newborn drug testing.
-
Magnesium Sulfate Before Preterm Birth for Neuroprotection: An Updated Cochrane Systematic Review. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-06-03 Emily S Shepherd, Shona Goldsmith, Lex W Doyle, Philippa Middleton, Stéphane Marret, Dwight J Rouse, Peter Pryde, Hanne T Wolf, Caroline A Crowther
To systematically review the evidence for the effectiveness and safety of magnesium sulfate as a fetal neuroprotective agent when given to individuals at risk of preterm birth.
-
Pregnancy-Related Deaths Due to Hemorrhage: Pregnancy Mortality Surveillance System, 2012-2019. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-30 Lisa M Hollier, Ashley Busacker, Fanny Njie, Carla Syverson, David A Goodman
Hemorrhage has been a leading cause of pregnancy-related death in the Centers for Disease Control and Prevention Pregnancy Mortality Surveillance System since 1987 when reporting began. Pregnancy Mortality Surveillance System data from 2012 to 2019 were analyzed to describe pregnancy-related deaths from hemorrhage. Pregnancy-related mortality ratios were estimated for hemorrhage overall and by hemorrhage
-
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Ayodeji A Sanusi, Justin Leach, Kim Boggess, Lorraine Dugoff, Baha Sibai, Kirsten Lawrence, Brenna L Hughes, Joseph Bell, Kjersti Aagaard, Rodney K Edwards, Kelly S Gibson, David M Haas, Lauren Plante, Torri D Metz, Brian Casey, Sean Esplin, Sherri Longo, Matthew K Hoffman, George R Saade, Kara K Hoppe, Janelle Foroutan, Methodius Tuuli, Michelle Y Owens, Hyagriv N Simhan, Heather Frey, Todd Rosen
To evaluate maternal and neonatal outcomes by type of antihypertensive used in participants of the CHAP (Chronic Hypertension in Pregnancy) trial.
-
Prevalence of Weight Stigma in Medical Settings Among Reproductive-Aged Women in the All of Us Study. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Olivia Kapera, Baojiang Chen, Jaime P Almandoz, Courtney Byrd-Williams, Sarah E Messiah
To analyze health care treatment experiences among a diverse cohort of reproductive-aged women from the All of Us study, focusing on variations due to body mass index (BMI).
-
Postmenopausal Bleeding After Coronavirus Disease 2019 (COVID-19) Vaccination: Vaccine Adverse Event Reporting System. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Penelope Strid, Winston E Abara, Elizabeth Clark, Pedro L Moro, Christine K Olson, Julianne Gee
We identified U.S. reports of postmenopausal bleeding in the VAERS (Vaccine Adverse Event Reporting System) between December 13, 2020, and December 13, 2021. Among 711,224 VAERS reports after coronavirus disease 2019 (COVID-19) vaccination, during our study period, we identified 554 presumptive postmenopausal bleeding reports; 434 were further classified as verified based on data abstracted from reports
-
Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Matthew D Moore, Hui-Chien Kuo, Rachel G Sinkey, Kim Boggess, Lorraine Dugoff, Baha Sibai, Kirsten Lawrence, Brenna L Hughes, Joseph Bell, Kjersti Aagaard, Rodney K Edwards, Kelly S Gibson, David M Haas, Lauren Plante, Torri D Metz, Brian Casey, Sean Esplin, Sherri Longo, Matthew K Hoffman, George R Saade, Kara K Hoppe, Janelle Foroutan, Methodius Tuuli, Michelle Y Owens, Hyagriv N Simhan, Heather
To estimate the association between mean arterial pressure during pregnancy and neonatal outcomes in participants with chronic hypertension using data from the CHAP (Chronic Hypertension and Pregnancy) trial.
-
24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Raanan Meyer, Shlomi Toussia-Cohen, Maya Shats, Omri Segal, Aya Mohr-Sasson, Shiran Peretz-Bookstein, Daphna Amitai-Komem, Ofra Sindel, Gabriel Levin, Roy Mashiach, Paul D Blumenthal
To compare 24-hour and 12-hour mifepristone-to-misoprostol intervals for second-trimester medication abortion.
-
Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Bonnie B Song, Zachary S Anderson, Aaron D Masjedi, Matthew W Lee, Rachel S Mandelbaum, Maximilian Klar, Lynda D Roman, Jason D Wright, Koji Matsuo
To describe population-level utilization of fertility-sparing surgery and outcome of reproductive-aged patients with early epithelial ovarian cancer who underwent fertility-sparing surgery in the United States.
-
Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Charles E Padgett, Yuanfan Ye, Macie L Champion, Rebecca E Fleenor, Vasiliki B Orfanakos, Brian M Casey, Ashley N Battarbee
To evaluate the association between continuous glucose monitoring in pregnant people with type 2 diabetes and perinatal outcomes.
-
Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-23 Rebecca G Simmons, Gentry Carter, Jessica N Sanders, David K Turok
To assess contraceptive switching and discontinuation among participants enrolled in a contraceptive access project over 3 years and to identify variables associated with contraceptive change.
-
Retained Tampon Fragment as an Unusual Cause of Vesicovaginal Fistula. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-21 Vienne Seitz, Emily R W Davidson
Vesicovaginal fistula (VVF) is an uncommon cause of urinary incontinence (UI). Iatrogenic etiologies, especially abdominal hysterectomy, are most common; however, a minority of VVFs are caused by retained foreign bodies. Objects associated with VVF include intrauterine devices, gauze, pessaries, bottle caps, and sexual aids, but retained tampons or other menstrual products have not been commonly reported
-
Hysterectomy Techniques and Outcomes for Benign Large Uteri: A Systematic Review. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-15 Mamta M Mamik, Shunaha Kim-Fine, Linda Yang, Vidya Sharma, Rajiv Gala, Sarit Aschkenazi, David Sheyn, David Howard, Andrew J Walter, Bela Kudish, Ethan M Balk, Danielle D Antosh
To identify the optimal hysterectomy approach for large uteri in gynecologic surgery for benign indications from a perioperative morbidity standpoint.
-
Prophylactic Unfractionated Heparin in Antepartum Hospitalizations: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-14 Thalia Mok, Anissa V Nguyen, Lorna Kwan, Irving Steinberg, Cristianna Vallera, Neil S Silverman, Rashmi Rao
To assess the effect of gestational age-based dosing of unfractionated heparin (UFH) compared with standard dosing of UFH for thromboprophylaxis on an elevated serum activated partial thromboplastin time (aPTT) during prolonged antepartum hospitalizations.
-
Development and Validation of an Automated, Real-Time Predictive Model for Postpartum Hemorrhage. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-10 Holly B Ende, Henry J Domenico, Aleksandra Polic, Amber Wesoloski, Lisa C Zuckerwise, Allison B Mccoy, Annastacia R Woytash, Ryan P Moore, Daniel W Byrne
To develop and validate a predictive model for postpartum hemorrhage that can be deployed in clinical care using automated, real-time electronic health record (EHR) data and to compare performance of the model with a nationally published risk prediction tool.
-
First-Trimester Ultrasound Screening in Routine Obstetric Practice. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-09 Bryann Bromley, Lawrence D Platt
Technologic advances and ultrasonographer-physician experience in fetal imaging have led to significant improvements in our ability to distinguish between normal and abnormal fetal structural development in the latter part of the first trimester. As a critical component of pregnancy care, assessment of fetal anatomy at the end of the first trimester with a standardized imaging protocol should be offered
-
Long-Term Risk of Type 2 Diabetes After Preterm Delivery or Hypertensive Disorders of Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-09 Casey Crump, Jan Sundquist, Kristina Sundquist
To examine long-term diabetes risk after preterm delivery or hypertensive disorders of pregnancy in a large population-based cohort.
-
Cannabidiol-Only Product Use in Pregnancy in the United States and Canada: Findings From the International Cannabis Policy Study. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-09 Devika Bhatia, Sharonya Battula, Susan Mikulich-Gilbertson, Joseph Sakai, David Hammond
This study aimed to characterize pregnant individuals' use of cannabidiol (CBD). Data are from the International Cannabis Policy Study (2019-2021), a repeated cross-sectional survey of individuals aged 16-65 years in the United States and Canada (N=66,457 women, including 1,096 pregnant women). The primary analysis compared pregnant and nonpregnant women's CBD-only product use patterns and reasons
-
Pipelle Endometrial Sampling With a Full Bladder Compared With Standard Care: A Randomized Controlled Trial. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-06 Erwina Hashim, Jesrine Hong, Yin Ling Woo, Mukhri Hamdan, Peng Chiong Tan
To compare insertion failure rates for Pipelle endometrial sampling with a full bladder compared with the standard process (not taking into account bladder status) without cervical manipulation.
-
Health Care Utilization by Patients With Chronic Pelvic Pain. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-02 Isabel Green, Morgan Briggs, Diana Encalada Soto, Kristin Cole, Jenna Wygant, Tatnai Burnett, Xuan Zhu, Innie Chen, Lindsey R Sangaralingam, Viengneesee Thao
To describe the patterns of health care utilization among patients with chronic pelvic pain.
-
Surgical Field Separation in Total Laparoscopic Hysterectomy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-02 Raanan Meyer, Clarissa Niino, Rebecca Schneyer, Kacey Hamilton, Matthew T Siedhoff, Kelly N Wright
We aimed to study whether separating the vaginal and abdominal surgical fields during total laparoscopic hysterectomy (TLH) is associated with surgical site infection rates. This was a retrospective cohort study of all patients who underwent TLH and any concomitant procedures with two minimally invasive gynecologic surgery subspecialists between January 2016 and May 2023. Among 680 included patients
-
Assessment of a Decade of Change in U.S. Assisted Reproductive Technology Cumulative Live-Birth Rates: 2004-2009 Compared With 2014-2020. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-05-02 Sarah F Wang, David B Seifer
To assess the effects of demographic shifts, changes in contemporaneous clinical practices, and technologic innovation on assisted reproductive technology (ART) success rates by conducting an analysis of cumulative live-birth rates across different time periods, age groups, and infertility diagnoses.
-
Regenerative Medicine in Gynecology. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-25 Julia L Balough, Pamela Moalli
The female reproductive tract undergoes dynamic changes across the life span. Congenital abnormalities, life events, and medical interventions can negatively affect the structure and function of reproductive tract organs, resulting in lifelong sequelae. The objective of regenerative gynecology is to discover and promote endogenous mechanisms by which a healthy tissue maintains overall tissue integrity
-
Evaluation of Sleep in Pregnant Inpatients Compared With Outpatients. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-25 Danielle M Panelli, Hayley E Miller, Samantha L Simpson, Janet Hurtado, Chi-Hung Shu, Ana C Boncompagni, Jane Chueh, Fiona Barwick, Brendan Carvalho, Pervez Sultan, Nima Aghaeepour, Maurice L Druzin
To evaluate whether antepartum hospitalization was associated with differences in sleep duration or disrupted sleep patterns.
-
Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-17 Kimberly K Vesco, Anna E Denoble, Heather S Lipkind, Elyse O Kharbanda, Malini B DeSilva, Matthew F Daley, Darios Getahun, Ousseny Zerbo, Allison L Naleway, Lisa Jackson, Joshua T B Williams, Thomas G Boyce, Candace C Fuller, Eric S Weintraub, Gabriela Vazquez-Benitez
To evaluate the association between antenatal messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination and risk of adverse pregnancy outcomes.
-
Syphilis Treatment Among People Who Are Pregnant in Six U.S. States, 2018-2021. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-17 Ayzsa Tannis, Kathryn Miele, Jeffrey M Carlson, Kevin P O'Callaghan, Kate R Woodworth, Breanne Anderson, Aisha Praag, Kourtney Pulliam, Nicole Coppola, Teri' Willabus, Deborah Mbotha, Dejene Abetew, Salvatore Currenti, Nicole D Longcore, Amanda Akosa, Dana Meaney-Delman, Van T Tong, Suzanne M Gilboa, Emily O Olsen
To describe syphilis treatment status and prenatal care among people with syphilis during pregnancy to identify missed opportunities for preventing congenital syphilis.
-
Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-16 Umair Masood, Nicholas Venturini, Paola Nicoletti, Andrew Dellinger, David Kleiner, Herbert L Bonkovsky, Huiman Barnhart, Raj Vuppalanchi, Simona Rossi, Joseph A Odin, Tatyana Kushner
There are limited data on the causative agents and characteristics of drug-induced liver injury in pregnant individuals. Data from patients with drug-induced liver injury enrolled in the ongoing multicenter Drug-Induced Liver Injury Network between 2004 and 2022 and occurring during pregnancy or 6 months postpartum were reviewed and compared with cases of drug-induced liver injury in nonpregnant women
-
Neurologic Emergencies in Pregnancy. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-16 Shaun R Wesley, G Edward Vates, Loralei L Thornburg
Neurologic emergencies in pregnancy require prompt evaluation and early, focused intervention to improve neurologic outcomes for the affected person and to avoid further injury. Neurologic events in pregnancy, although rare, present a time of extreme risk of permanent injury for the person who is pregnant. Therefore, obstetric clinicians should be well versed in the risk factors for potential neurologic
-
National Postpartum Permanent Contraception Practices and Perceived Barriers. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-16 Ellen Murphy, Andrea Pelletier, Kathryn Fay, Deborah Bartz
Single institution-level studies have demonstrated low postpartum permanent contraception fulfillment rates after vaginal birth. To explore the national scope of the problem, we collected cross-sectional survey data from faculty at 109 U.S. academic medical centers to elicit perceptions about postpartum permanent contraception practices after vaginal birth, including barriers to and changes in practice
-
Pathophysiology and Clinical Implications of Ovarian Endometriomas. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-16 Farr R Nezhat, Ann M Cathcart, Ceana H Nezhat, Camran R Nezhat
Ovarian endometriomas affect many patients with endometriosis and have significant effects on quality of life, fertility, and risk of malignancy. Endometriomas range from small (1-3 cm), densely fibrotic cysts to large (20 cm or greater) cysts with varying degrees of fibrosis. Endometriomas are hypothesized to form from endometriotic invasion or metaplasia of functional cysts or alternatively from
-
Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-11 Timothy Wen, Loralei L Thornburg, Mary E Norton, Lawrence D Platt, Lorraine Dugoff, Ashley Hesson, Jean L Spitz, Gregory Toland, Bryann Bromley
Nuchal translucency (NT) measurement in conjunction with serum analytes has been used for first-trimester aneuploidy screening in the United States since 2005. We sought to analyze the trends in reporting of NT measurements to the Nuchal Translucency Quality Review program in all pregnancies beginning after the clinical introduction of cell-free DNA (cfDNA) screening for fetal aneuploidy in 2011. Overall
-
Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-05 Rachel Stern, Moses Bibi, Martin D Keltz
Since the onset of the coronavirus disease (COVID-19) pandemic, a variety of long-COVID-19 symptoms and autoimmune complications have been recognized.
-
Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2-7 Years After Delivery. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-05 Kartik K Venkatesh, Sadiya S Khan, Lynn M Yee, Jiqiang Wu, Rebecca McNeil, Philip Greenland, Judith H Chung, Lisa D Levine, Hyagriv N Simhan, Janet Catov, Christina Scifres, Uma M Reddy, Victoria L Pemberton, George Saade, C Noel Bairey Merz, William A Grobman
To determine whether adverse pregnancy outcomes are associated with a higher predicted 30-year risk of atherosclerotic cardiovascular disease (CVD; ie, coronary artery disease or stroke).
-
Patient Location and Disparities in Access to Fertility Preservation for Women With Gynecologic or Breast Cancer. Obstet. Gynecol. (IF 5.7) Pub Date : 2024-04-05 Alexa Kanbergs, Kirsten Jorgensen, Nuria Agusti, David Viveros-Carreño, Chi-Fang Wu, Roni Nitecki, John A Harris, Terri Woodard, Ryan Ramphul, Jose Alejandro Rauh-Hain
To assess the effect of geographic factors on fertility-sparing treatment or assisted reproductive technology (ART) utilization among women with gynecologic or breast cancers.